on Cheplapharm Arzneimittel GmbH (isin : DE000CHP2222)
Sebastian Braun Honored as EY Entrepreneur of the Year
Sebastian Braun, Chairman and co-owner of CHEPLAPHARM, has been awarded the EY Entrepreneur of the Year in the ‘family business’ category. This accolade marks the first time a representative from eastern Germany has won since 2014. Presented globally in 60 countries, this award is one of the most esteemed in the business sector.
Under Braun's leadership, CHEPLAPHARM transitioned from a small enterprise to a global leader in the off-patent branded medicines market, achieving a turnover of 1.5 billion euros in 2023. The company, employing 750 people across multiple countries, ensures the provision of critical medicines internationally.
Braun attributes his success to a blend of preparation and opportunity, which resonated with the award's selection criteria: Entrepreneurship, Purpose, Growth, and Impact. As the eastern German pioneer, he expresses pride in his team’s role in this achievement.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cheplapharm Arzneimittel GmbH news